Taysha Gene Therapies
TSHA
#5355
Rank
ยฃ1.03 B
Marketcap
ยฃ3.79
Share price
-0.20%
Change (1 day)
94.73%
Change (1 year)

Revenue for Taysha Gene Therapies (TSHA)

Revenue in 2025 (TTM): ยฃ4.83 Million

According to Taysha Gene Therapies's latest financial reports the company's current revenue (TTM ) is ยฃ4.73 Million. In 2024 the company made a revenue of ยฃ6.64 Million a decrease over the revenue in the year 2023 that were of ยฃ12.12 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Taysha Gene Therapies from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ4.83 M-27.12%
2024 ยฃ6.64 M-45.25%
2023 ยฃ12.12 M486.43%
2022 ยฃ2.06 M
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA